OPTEC (Ohio Prevention and Treatment of Endometrial Cancer) is a statewide initiative to help identify women with endometrial cancer who may be at risk for other types of cancers due to their genetic makeup, and to help match women with endometrial cancer to the best treatment options for their particular cancer. Some endometrial cancer results from an inherited condition called Lynch syndrome. While Lynch syndrome is rare &mdash; only about 5 in 100 people with endometrial cancer have Lynch syndrome &mdash; it greatly increases the chance of developing many other types of cancer. Women enrolled in OPTEC will receive free screening for Lynch syndrome. Additionally, as part of the OPTEC initiative, we will establish a registry for patients and their families with Lynch syndrome. All women enrolled in OPTEC will receive free tumor testing to identify the molecular changes that are causing their endometrial cancer, regardless of whether or not they are found to be likely to have Lynch syndrome. This testing may allow us to identify the best therapy or clinical trial to treat each individual cancer. Click here to learn more about OPTEC, and find out how to participate in the program.